Showing results (21-30 of 333) with videos related to

Sort By:
Pageof 34
American Journal of Obstetrics and Gynecology|November 1, 1993
A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestinsD Crook, I F Godsland, M Worthington, et al.
Obstetrics and Gynecology|August 1, 1994
Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrationsS I Whitcroft, D Crook, M S Marsh, et al.
Contraception|September 1, 1993
Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolismI F Godsland, D Crook, M Worthington, et al.
Maturitas|August 6, 2002
Effect of postmenopausal oestradiol and dydrogesterone therapy on lipoproteins and insulin sensitivity, secretion and elimination in hysterectomised womenN A Manassiev, I F Godsland, D Crook, et al.
Clinical Endocrinology|April 24, 2004
Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal womenI F Godsland, N A Manassiev, C V Felton, et al.
American Journal of Obstetrics and Gynecology|March 1, 1992
Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteinsD Crook, M P Cust, K F Gangar, et al.
British Journal of Obstetrics and Gynaecology|December 9, 1997
The metabolic consequences of treating postmenopausal women with non-oral hormone replacement therapyD Crook
Contraception|April 1, 1997
Multicenter study of endocrine function and plasma lipids and lipoproteins in women using oral contraceptives containing desogestrel progestin. UK Desogen Study GroupD Crook
British Heart Journal|July 1, 1995
Insulin resistance syndrome in postmenopausal women with cardiological syndrome XI F Godsland, D Crook, J C Stevenson, et al.
The American Journal of the Medical Sciences|April 1, 1999
The role of hypertension, obesity, and diabetes in causing renal vascular diseaseE D Crook
Pageof 34